Dilon Diagnostics announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its lesion-localization system for molecular imaging biopsy guidance.
GammaLoc(®), pronounced “gamma-loke”, is a complementary technology to Dilon’s cornerstone product, the Dilon 6800(®) Gamma Camera. The GammaLoc(®) (GL) system will help doctors accurately locate breast lesions and enable gamma-guided biopsies, particularly [...]

Agios Pharmaceuticals has announced that its scientists have established, for the first time, that the mutated IDH1 gene has a novel enzyme activity consistent with a cancer-causing gene, or oncogene. This breakthrough discovery shows that the mutated form of IDH1 produces a metabolite, 2-hydroxyglutarate (2HG), which may contribute to the formation and malignant progression of [...]

A condition that affects the memory and concentration of cancer patients undergoing chemotherapy is sustained in a subgroup of patients, compromising their ability to function and long-term quality of life, according to research presented on wednesday at a major cancer conference.

Embryos that are most likely to result in a pregnancy are crucial to the success of in vitro fertilization (IVF) but are difficult to identify. Researchers at Yale School of Medicine, led by Emre Seli, M.D., are developing a fast, non-invasive test to help assess embryo viability for IVF.

Researchers from Turku, Finland, have identified a blood-flow glucose consumption mismatch that predicted pancreatic tumor aggressiveness, according to results of a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research.